Dicerna Pharmaceuticals

Dicerna

This biotechnology firm develops ribonucleic acid interference therapies for patients with rare genetic, cardiovascular and liver diseases through a proprietary gene-silencing technology platform.

Novarna

This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.

Argonaute RNA

This biotechnology firm develops bispecific siRNA therapeutics for cardiometabolic diseases, serving pharmaceutical partners and research institutions engaged in advanced therapeutic research.

Regeneron

This biopharmaceutical company develops medicines for serious diseases, including eye conditions, cancer and inflammatory disorders, for healthcare providers and global patients.

Ribometrix

The company develops small molecule therapeutics targeting RNA structures to treat human diseases for pharmaceutical partners and patients with cancer or neurodegenerative conditions.

Atea

This biopharmaceutical company develops oral antiviral therapies for patients with serious viral infections, including hepatitis C and other ribonucleic acid virus diseases.

Airna

This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.

Averna Therapeutics

This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.